Clinical Trials Logo

Filter by:
NCT ID: NCT05524974 Not yet recruiting - Clinical trials for Locally Advanced Gastric Cancer

Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes

Start date: September 1, 2022
Phase: Phase 2
Study type: Interventional

To evaluate the clinical efficacy of camrelizumab, apatinib Mesylate and nab-paclitaxel combined with oxplatin and S-1 in the neoadjuvant treatment of locally advanced gastric cancer with different genotypes

NCT ID: NCT05524922 Recruiting - Clinical trials for Neurodegenerative Disorder

A Registered Cohort Study on Neurodegenerative Associated With Disorders Sleep Disorder.

Start date: September 1, 2021
Phase:
Study type: Observational

Cognitive impairment often appears in neurodegenerative diseases, and it is expected to further study the mechanism of sleep disorders associated with the progression of neurodegenerative diseases by exploring the clinical manifestations, imaging, and biological marker changes of sleep disorders in neurodegenerative diseases.

NCT ID: NCT05524675 Recruiting - Dyspepsia Clinical Trials

The Effect of Multiple Medications on the Incidence of Organic Dyspepsia

Start date: June 1, 2022
Phase:
Study type: Observational

Dyspepsia is a very common gastrointestinal disease, presented as predominant symptom of upper abdominal pain. Underlying causes for dyspepsia can classified as organic or functional dyspepsia. Some medications (eg. non-steroid anti-inflammatory drugs (NSAIDs)) were associated with higher frequent incidences of organic lesions. Multiple medications showed an increased trend with aging of the population and multimorbidity. Multiple medications were suggested to be strongly relate to adverse drug events (ADEs), adverse drug reactions (ADRs), drug-drug interactions, and drug-disease interactions, which had been reported to lead to higher incidences of some diseases, including fractures, cognitive impairment and malnutrition. However, it was unknown if multiple medications was associated with more incidences of organic dyspepsia.

NCT ID: NCT05524519 Completed - Clinical trials for Major Depressive Disorder

Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Acupoints are the stimulus points and reactive points for acupuncture to treat diseases. Therefore, this study is designed to detect the pain threshold and temperature of biological specificities of acupoints in healthy control (HC) participants and major depressive disorder (MDD) participants by using pressure pain threshold gauge (PTG) and infrared thermography (IRT). Based on the results of the PTG and IRT tests, the potentially superior acupoints for the treatment of MDD will be selected separately. Then, different acupoint groups selected based on different biological specificities tests will be used for clinical treatment to evaluate the clinical efficacy of intradermal acupuncture (IA) for MDD based on changes in the biological specificities of acupoints.

NCT ID: NCT05524285 Recruiting - Clinical trials for Intracranial Aneurysm

Safety Study of Intracranial Support Catheter and Guide Catheter for Stent-Assisted Embolization in the Treatment of Intracranial Aneurysms

SAFETI
Start date: February 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety differences between intracranial support catheter and guide catheter for stent-assisted embolization in the treatment of unruptured intracranial aneurysms in the anterior circulation.

NCT ID: NCT05524207 Recruiting - Carotid Stenosis Clinical Trials

Carotid Artery Stent Implantation in the Treatment of Vulnerable Plaque

CASTLE
Start date: January 1, 2022
Phase:
Study type: Observational

To investigate the efficacy and safety of carotid stenting for vulnerable carotid plaques. All patients with carotid artery stenosis underwent carotid arterial contrast-enhanced ultrasonography before operation. According to the examination results, they were divided into two groups: vulnerable plaque group and stable plaque group. The incidence of perioperative stroke events in the two groups was compared. The incidence of stroke events in the two groups within 1 year was compared.

NCT ID: NCT05524168 Recruiting - Clinical trials for Nasopharyngeal Carcinoma

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Start date: November 25, 2022
Phase: Phase 2
Study type: Interventional

This is a multicenter, single-arm, phase II clinical trial. The purpose of this study is to evaluate the efficacy and adverse effect of SBRT combined with programmed death 1 (PD-1) antibody and chemotherapy in nasopharyngeal carcinoma patients with oligometastasis.

NCT ID: NCT05524142 Recruiting - Atrial Fibrillation Clinical Trials

Association Between ALDH2 Gene Polymorphism and Atrial Fibrillation

AAAF
Start date: May 20, 2022
Phase:
Study type: Observational

This study is a case-control study. In this study, 2ml of vein blood samples were collected from patients with atrial fibrillation undergoing radiofrequency ablation and those in the control group who underwent electrophysiological examination alone and confirmed no arrhythmia. The purpose of this study is to identify the relationship between the aldehyde dehydrogenase 2 (ALDH2) gene polymorphism and susceptibility to atrial fibrillation, and to explore the relationship between the genotype of ALDH2 SNP and the prognosis of patients with atrial fibrillation undergoing radiofrequency ablation.

NCT ID: NCT05524103 Recruiting - Clinical trials for Acute Spinal Cord Injury

Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury

Start date: April 15, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of ALMB-0166 in patients with acute spinal cord injury.

NCT ID: NCT05523960 Completed - Esophageal Cancer Clinical Trials

Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The study type was designed as a prospective multicenter randomized controlled study. The patients will be divided into intervention group and control group, 281 patients were needed for each group and 562 patients would be needed totally to show this difference. Due to a possible loss of 14%, the final sample size was calculated to be 652 patients. The intervention group will not implement mechanical bowel preparation(MBP) before surgery; the control group will receive routine preoperative MBP for oral administration of compound polyethylene glycol electrolyte powder and fasting water. Perioperative complications, intestinal recovery speed and quality of life will be investigated between the two groups.